Abstract:Urolithin A, an active precursor derived from the metabolism of ellagitanins in rats and humans, is known for its potential health benefits, including stimulating mitophagy and promoting muscular skeletal function. While experimental studies have demonstrated Urolithin A's potential to enhance cellular health, the detailed molecular interactions through which Urolithin A exerts its effects are not fully elucidated. In this study, we investigated the anti-inflammatory, antioxidation and neuroprotective abilities of Urolithin A in selected targets using molecular docking and molecular dynamics simulation methods. Molecular docking studies revealed the strong affinity for receptors involved in inflammation activities, including human p38 MAP kinase (4DLI) with −10.1 kcal/mol interacting with SER252, LYS249, and ASP294 residues. The binding energy in the 5KIR target was −8.6 kcal/mol, interacting with GLN203 through hydrogen bond, and lastly, 1A9U with an affinity of −6.8 with no hydrogen bond formed with Urolithin A and interacts with van der Waals interactions. In oxidant targets, the influence of Urolithin was observed in 1OG5 with −7.9 kcal/mol interacting with GLN185, PHE447. For the 1M17 target, the binding affinity was −7.7 kcal/mol interacting with THR95 residue and 1ZXM target at −7.4 kcal/mol interacting with TYR36, TYR216, and LEU234 residues. The neuroprotective ability of urolithin A was observed in selected targets for acetylcholinesterase; the binding energy was −9.7 kcal/mol interacting with van der Waals and π interactions; for the 1GQR target, the binding energy was −9.9 kcal/mol interacting with van der Waals and π interactions and for β-amylase (1iyt) the binding energy was −5.5 forming hydrogen bond with SER8, GLN15 residues. Molecular Dynamics simulations at 100 ns of Urolithin A compared with reference 4DLI. The Urolithin A-4DLI complex exhibited greater stability than the reference receptor, as confirmed by RMSD, RMSF, Radius of Gyration, Hydrogen bond, and SASA analyses.

Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota

A mechanistic insight into the biological activities of urolithins as gut microbial metabolites of ellagitannins

Gut Bacteria Involved in Ellagic Acid Metabolism To Yield Human Urolithin Metabotypes Revealed

Health functions and related molecular mechanisms of ellagitannin-derived urolithins

NMR Spectroscopic Identification of Urolithin G, a Novel Trihydroxy Urolithin Produced by Human Intestinal Enterocloster Species

Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins

Therapeutic efficacy of gut microbiota-derived polyphenol metabolite Urolithin A

Urolithins and intestinal health

Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress

Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes

In vivo administration of gut bacterial consortia replicates urolithin metabotypes A and B in a non-urolithin-producing rat model

Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation

Impact of the Natural Compound Urolithin A on Health, Disease, and Aging

Urolithin A production drives the pomegranate effects on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals

The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies

Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases

The gut microbiota metabolite urolithin A, but not other relevant urolithins, induces p53-dependent cellular senescence in human colon cancer cells

The Impact of Ellagitannins and Their Metabolites through Gut Microbiome on the Gut Health and Brain Wellness within the Gut–Brain Axis

Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells

Urolithin A and Ellagic Acid Inhibit Prostate Cancer Through Different Molecular Mechanisms: Implications of Gut Microbiome Metabolism for Cancer Prevention

Computational Investigation of Urolithin A Binding Affinities and Dynamics on Targets Implicated in Anti-inflammatory, Antioxidant, and Neurodegenerative Pathways